SCHEMBL7789996

SCHEMBL7789996

CN(Cc1cccnc1)c1cc(F)cc(F)c1

nearest known ligand 0.57

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 2/20 0.57
CHRNA4 P43681 2/20 0.57
CYP3A4 P08684 4/20 0.49
DHODH Q02127 2/20 0.46
CHRNA7 P36544 1/20 0.46
GBA1 P04062 1/20 0.43
PKM P14618 1/20 0.43
ALDH1A1 P00352 3/20 0.43
RIPK1 Q13546 1/20 0.43
KDM4E B2RXH2 1/20 0.43
LMNA P02545 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19212236 0.80 NR1H2 (0.49) ALDH1A1KDM4E
SCHEMBL6608225 0.76 CHRNB2 (0.59) CHRNB2CHRNA4DHODHCHRNA7GBA1
SCHEMBL10987362 0.76 CHRNB2 (0.59) CHRNB2CHRNA4DHODHCHRNA7GBA1
SCHEMBL6413923 0.76 CHRNB2 (0.46) CHRNB2CHRNA4CYP3A4CHRNA7ALDH1A1
SCHEMBL22928701 0.76 CHRNB2 (0.75) CHRNB2CHRNA4CHRNA7ALDH1A1RIPK1
SCHEMBL12888668 0.75 CHRNB2 (0.67) CHRNB2CHRNA4CHRNA7GBA1ALDH1A1
SCHEMBL30632262 0.74 CHRNB2 (1.00) CHRNB2CHRNA4CHRNA7ALDH1A1RIPK1
SCHEMBL3460939 0.74 CHRNB2 (1.00) CHRNB2CHRNA4CHRNA7ALDH1A1RIPK1
SCHEMBL10028665 0.74 CHRNB2 (0.85) CHRNB2CHRNA4CHRNA7ALDH1A1RIPK1
SCHEMBL2227055 0.73 CHRNB2 (0.55) CHRNB2CHRNA4CHRNA7GBA1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1150963-A1 SUBSTITUTED 4-AMINO-2-ARYLTETRAHYDROQUINAZOLINES, THEIR PREPARATION, THEIR USE AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM Aventis Pharma Deutschland GmbH (DE) 2001-11-07 EP disclosed
WO-2000046214-A1 SUBSTITUTED 4-AMINO-2-ARYLTETRAHYDROQUINAZOLINES, THEIR PREPARATION, THEIR USE AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2000-08-10 WO disclosed